April 03, 2026

Botulinum Toxin Evaluated in Digital Ischemia

Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

Conexiant

April 02, 2026

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted

Conexiant

April 01, 2026

Case Report Shows Carbimazole's ‘Triple-Hit’

Diffuse alveolar hemorrhage with coexistent antiphospholipid syndrome complicated anticoagulation therapy and created competing bleeding and thrombosis risks.

Conexiant

April 01, 2026

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Conexiant

March 31, 2026

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

Conexiant

March 30, 2026

Top 10 States With the Most Favorable Tax Climate for Physicians

These 10 states differ in how they structure income, property, and sales taxes—factors that can influence overall tax exposure for physicians.

Conexiant

March 30, 2026

Extended Viral PCR: Does It Help?

Researchers evaluate whether extended viral PCR testing is associated with antibiotic use and length of stay in adult inpatients.

Conexiant

March 27, 2026

FDA Drops Age Limit for Neffy

Needle-free epinephrine expands access for younger children meeting weight criteria

Conexiant

March 27, 2026

FDA Approves Gene Therapy for Severe Pediatric LAD-I

Approval expands treatment option for a rare pediatric immunodeficiency

Conexiant

March 27, 2026

Airway Resistome Higher In Chronic Lung Disease

Recent antibiotic exposure was linked to greater antimicrobial resistance gene burden in bronchoscopy samples of patients with chronic lung disease.

Conexiant